Human fibrin is a physiologic delivery system for bone morphogenetic protein

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Research

Background:

• Bone morphogenetic proteins (BMPs) are crucial for bone regeneration.
• Effective delivery systems are needed to maximize BMP efficacy.
• Fibrin has been explored as a biocompatible scaffold for tissue engineering.

Purpose of the Study:

• To evaluate a fibrin clot composite as a delivery system for BMP/noncollagenous proteins (NCP).
• To compare new bone formation using the composite versus BMP/NCP alone and fibrin alone.
• To assess the potential of fibrin as an immunochemical agent and BMP distributor.

Main Methods:

• Implantation of BMP/NCP fibrin composite, BMP/NCP alone, and fibrin alone in mouse thighs.
• Quantification of new bone by random point analysis and ash weight measurement.
• Histologic and microradiographic examination of bone formation at early time points.

Main Results:

• The BMP/NCP fibrin composite produced significantly more new bone (approximately three times) than BMP/NCP alone.
• Histologic examination showed greater mesenchymal cell proliferation with the composite.
• Both wet clot and lyophilized composites demonstrated enhanced bone formation compared to BMP alone.

Conclusions:

• Fibrin clot serves as an effective delivery system and potential immunochemical agent for BMP.
• The composite system significantly enhances new bone yield compared to BMP alone.
• A human fibrin delivery system for BMP warrants further investigation for orthopedic applications.